Carina Wattmo
21 – 30 of 88
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies : A cross-sectional study in 40 nursing homes in Sweden
(
- Contribution to journal › Article
- 2017
-
Mark
Early- versus late-onset Alzheimer disease : Long-term functional outcomes, nursing home placement, and risk factors for rate of progression.
(
- Contribution to journal › Article
-
Mark
The outcomes of different assessment scales can predict survival in patients with Alzheimer’s disease
2017) 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2017) In Neurodegenerative Diseases 17(Suppl. 1). p.27-27(
- Contribution to journal › Published meeting abstract
-
Mark
Response to the Letter From Abid Iraqi, MD, CMD and Terry Hughes, RN, CS
(
- Contribution to journal › Letter
-
Mark
The course and end-points of Alzheimer’s disease according to sociodemographics, apolipoprotein E genotype and cognitive ability.
2017) Alzheimer's Association International Conference (AAIC), 2017(
- Contribution to conference › Poster
-
Mark
Early- versus late-onset Alzheimer's disease in clinical practice : Cognitive and global outcomes over 3 years
(
- Contribution to journal › Article
-
Mark
Dementia with Lewy Body (DLB) Symptoms Hidden within the Diagnosis “Dementia Not Otherwise Specified” a Cross-Sectional Study in 40 Swedish Nursing Homes.
2017) Alzheimer's Association International Conference (AAIC), 2017(
- Contribution to conference › Poster
-
Mark
Equity in dementia care focusing on immigrants in Sweden: a nationwide register-based study.
2017) 10th European Public Health Conference (EPH) In European Journal of Public Health 27(suppl_3). p.51-51(
- Contribution to journal › Published meeting abstract
-
Mark
Levels of cerebrospinal fluid biomarkers total tau and phosphorylated tau do not predict survival time after diagnosis of Alzheimer’s disease – An 18-year follow-up.
2017) 10th Clinical Trials Conference on Alzheimer’s Disease(
- Contribution to conference › Poster
- 2016
-
Mark
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
(
- Contribution to journal › Article